Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim–Chester disease

Abstract Background Erdheim–Chester disease (ECD) is a rare multi-systemic form of histiocytosis. Treatment with BRAF inhibitors has markedly improved outcomes of ECD; however, this targeted therapy is expensive (estimated annual cost is $50,000). Since estimated annual cost of interferon-α (IFN-α)...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Xin-xin Cao, Na Niu, Jian Sun, Hao Cai, Feng-dan Wang, Yi-ning Wang, Ming-hui Duan, Dao-bin Zhou, Jian Li
פורמט: Artigo
שפה:Inglês
יצא לאור: BMC 2019-01-01
סדרה:Orphanet Journal of Rare Diseases
נושאים:
Erdheim–Chester disease
BRAF V600E mutation
Interferon-α
Positron-emission tomography
גישה מקוונת:http://link.springer.com/article/10.1186/s13023-018-0988-y
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים